New medications are boosting quality of life for many older people with age-related macular degeneration (AMD), a new study indicates.
The drugs Avastin and Lucentis have significantly increased the number of people with AMD whose vision remains good enough to do daily activities, such as read standard print or drive, researchers found.
Age-related macular degeneration is the leading cause of vision loss among older Americans, the U.S. National Eye Institute (NEI) says.
